Surveillance of pneumococcal disease in Australian states and territories.
Information on pneumococcal disease, including immunisation programs, and optimum future surveillance in each Australian State and Territory were discussed at the Pneumococcal Disease in Australia Workshop on 26-27 March 1999. Workshop participants further expanded on the surveillance aspects of the Workshop in this report. Most participants favoured notification by laboratories of pneumococcal isolates from sterile sites, to provide baseline surveillance data before immunisation programs are fully implemented. It was also thought that trends in antimicrobial resistance should be notified.
McIntyre
P
P
National Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases, Royal Alexandra Hospital for Children, Parramatta, New South Wales.
Menzies
R
R
Krause
V
V
Selvey
L
L
Hall
R
R
Misrachi
A
A
Andrews
R
R
Giele
C
C
Gill
J
J
D001315:Australia / Q000453:epidemiology; D001428:Bacterial Vaccines; D018563:Disease Notification; D004352:Drug Resistance, Microbial; D006801:Humans; D011008:Pneumococcal Infections / Q000453:epidemiology* / Q000517:prevention & control; D011159:Population Surveillance
D001428:Bacterial Vaccines